Who owns Provectus Biopharmaceuticals I?

Tip: Access positions for across all investors

Analyze quarterly positions in Provectus Biopharmaceuticals I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Provectus Biopharmaceuticals I stock

Who bought or sold Provectus Biopharmaceuticals I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Home Federal Bank Of Tennessee 100k $5.6k 0% Dec 2025
 View chart
Wealth Preservation Advisors 53k $2.9k 100% Dec 2025
 View chart
Academy Capital Management 20k $1.1k 0% Dec 2025
 View chart
Financial Symmetry 10k $569.676900 0% Dec 2025
 View chart
Huntington National Bank 1.00 $0 0% Dec 2025
 View chart

Who sold out of Provectus Biopharmaceuticals I?

Fund or Company Name Date Sold Shares Held Valued At
Atlas Wealth Sep 2025 27k $2.4k
LBMC Investment Advisors Sep 2025 20k $1.8k